169 results
Page 3 of 9
8-K
EX-99.1
ik5e00t
30 Apr 20
Soligenix Announces Positive Phase 3 FLASH Study Demonstrates Increased Efficacy with Continued Treatment in Patients with Cutaneous T-Cell Lymphoma
7:05am
8-K
EX-99.1
5qguxejnfaipq
19 Mar 20
Soligenix Announces Positive Top-line Results for its Pivotal Phase 3 FLASH Trial Evaluating SGX301 in Treatment of Cutaneous T-Cell Lymphoma
6:04am
8-K
EX-99.1
kjrq fkp5dd
14 Jan 20
Soligenix – Advancing to Important Inflection Points
1:05pm
8-K
EX-99.1
2y3opsm95mnu6p0pqgj0
17 Sep 19
Soligenix Appoints Daniel P. Ring as Vice President of Business Development and Strategic Planning
6:59am
8-K
EX-99.1
y11t3m
11 Sep 19
Soligenix Appoints Jonathan Guarino as Chief Financial Officer
4:15pm
8-K
EX-99.1
01k8 utvpcgi
29 Aug 19
Final topline results remain on target for first half 2020
4:30pm
8-K
EX-99.1
lrb8jt
9 Jul 19
Soligenix Announces Appointment of Diane L. Parks
12:00am
8-K
EX-99.1
ciyd5
23 Apr 19
Soligenix – Advancing to Important Inflection Points
4:16pm
8-K
EX-99.1
alfy6fkmv nzbj7b
15 Oct 18
Other Events
7:00am
8-K
EX-99.1
9y7l9c vn2wumuqg60
25 Jul 18
Soligenix Announces Appointment of
9:21am
8-K
EX-99.1
9hthicab
19 Jul 18
Other Events
6:30am
8-K
EX-99.2
s0q675
2 Jul 18
Soligenix, Inc. Prices $8,000,000 Public Offering At The Market
4:15pm
8-K
EX-99.1
uih gbxb2cl
2 Jul 18
Soligenix, Inc. Prices $8,000,000 Public Offering At The Market
4:15pm
424B4
yv8c 6ns8gu6uxzykt
29 Jun 18
Prospectus supplement with pricing info
12:00am